Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Familial Cancer
Published in: Familial Cancer 2/2003

01-06-2003

Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma

Authors: Brindusa Truta, Brian A. Allen, Peggy G. Conrad, Young S. Kim, Terri Berk, Steven Gallinger, Bharati Bapat, Jonathan P. Terdiman, Marvin H. Sleisenger

Published in: Familial Cancer | Issue 2/2003

Login to get access
Metadata
Title
Genotype and phenotype of patients with both familial adenomatous polyposis and thyroid carcinoma
Authors
Brindusa Truta
Brian A. Allen
Peggy G. Conrad
Young S. Kim
Terri Berk
Steven Gallinger
Bharati Bapat
Jonathan P. Terdiman
Marvin H. Sleisenger
Publication date
01-06-2003
Publisher
Kluwer Academic Publishers
Published in
Familial Cancer / Issue 2/2003
Print ISSN: 1389-9600
Electronic ISSN: 1573-7292
DOI
https://doi.org/10.1023/A:1025762706854

Other articles of this Issue 2/2003

Familial Cancer 2/2003 Go to the issue

OriginalPaper

Histopathological characteristics of BRCA1- and BRCA2-associated intraperitoneal cancer: a clinic-based study

OriginalPaper

Bannayan–Riley–Ruvalcaba syndrome: further delineation of the phenotype and management of PTEN mutation-positive cases

Abstract List

Abstracts presented at the Spring Conference 2003 of the Cancer Genetics Group, 12–13 May 2003, Southampton, UK

ReviewPaper

Familial melanoma: a complex disorder leading to controversy on DNA testing

Abstract List

Abstracts presented at the XVIth symposium of The Netherlands Foundation for the Detection of Hereditary Tumours, 'New Developments in Hereditary Cancer', 31 January 2003, Utrecht, The Netherlands

OriginalPaper

Spouse controls in family case-control studies: a methodological consideration
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits